CalciMedica, Inc. — Director's Dealing 2023

Mar 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GRAYBUG VISION, INC. (GRAY)
CIK: 0001534133
Period of Report: 2023-03-03

Reporting Person: Zamiri Parisa (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-03	Common Stock	M	120655	—	Acquired	178232	Direct
2023-03-03	Common Stock	F	42894	$0.57	Disposed	135338	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-03	Restricted Stock Units	$	M	9375	Disposed		Common Stock (9375)	Direct
2023-03-03	Restricted Stock Unit	$	M	83155	Disposed		Common Stock (83155)	Direct
2023-03-03	Restricted Stock Unit	$	M	28125	Disposed		Common Stock (28125)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3: The RSUs do not expire; they either vest or are canceled prior to vest date.

F4: The RSUs shall vested as to 100% of the total RSUs on February 28, 2023 and settled on March 3, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F5: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.